SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC
Surgery Partners, Inc. Common Stock
SGRY
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Last trade$26.81
Day change+$0.02 (+0.07%)
Day range$26.17 – $26.87
Volume1,134,550
Market cap$3.51B
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$3.51B
Price / earnings
—
Price / book
2.11×
Price / sales
1.04×
EV / sales
1.85×
EV / EBITDA
10.01×
Profitability
Earnings per share
-$0.66
Return on assets
-1.23%
Return on equity
-5.23%
Dividend yield
0%
Liquidity and leverage
Debt / equity
1.84×
Current ratio
2.17×
Quick ratio
2.01×
Cash ratio
0.71×
Cash flow
Price / cash flow
12.62×
Price / free cash flow
17.29×
Free cash flow
$202.8M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SGRY, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$815.3M
$848.9M
$810.9M
$885M
$821.5M
$826.2M
$776M
$864.4M
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$815.3M
$848.9M
$810.9M
$885M
$821.5M
$826.2M
$776M
$864.4M
Selling, general and administrative
$379.6M
$392.2M
$388M
$381.2M
$369.2M
$373.4M
$369.9M
$367.8M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$729.5M
$750.8M
$744.9M
$771.3M
$704.1M
$723M
$713.3M
$730.5M
Operating income
$85.8M
$98.1M
$66M
$113.7M
$117.4M
$103.2M
$62.7M
$133.9M
Interest expense
-$67.9M
-$69.8M
-$69.1M
$0
-$74.9M
-$67.9M
-$62.2M
$0
Income before taxes
$17.7M
$32.3M
-$3.3M
$42.6M
$30.8M
$43.8M
-$300K
$74.2M
Income taxes
$3.6M
$2.6M
-$1.2M
$13.6M
$5.5M
-$1.1M
$0
$120.8M
Net income
$14.1M
$29.7M
-$2.1M
$29M
$25.3M
$44.9M
-$300K
-$46.6M
Net income attributable to common shareholders
-$21.1M
-$15M
-$35.9M
-$15M
-$22.7M
-$2.5M
-$37.7M
-$108.5M
EBITDA
$148.4M
$155.8M
$122.6M
$193.4M
$174.6M
$161.6M
$125.9M
$206.9M
Basic earnings per share
-$0.16
-$0.12
-$0.28
-$0.12
-$0.18
-$0.02
-$0.30
-$0.86
Diluted earnings per share
-$0.16
-$0.12
-$0.28
-$0.12
-$0.18
-$0.02
-$0.30
-$0.86
Recent news
Company coverage with links to the original publishers.
The State Street SPDR S&P Health Care Services ETF (XHS) is a passively managed healthcare services sector ETF launched in 2011 with $240.63 million in assets. It offers low costs (0.35% expense ratio), diversified exposure across 63 holdings, and has gained 36.18% year-to-date and 43.08% over the past year. With a beta of 0.93 and Zacks ETF Rank of 3 (Hold), it represents a reasonable option for healthcare sector exposure, though it carries medium risk.
Surgery Partners (SGRY) reported Q3 2026 earnings of $0.16 per share, beating consensus estimates of $0.07 by 128.57%, though revenues slightly missed expectations at $815.3 million. Despite strong year-to-date performance of 50.2%, the company received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends, suggesting near-term underperformance relative to the market.
CVS Health reported Q3 2026 earnings of $2.09 per share, beating consensus estimates by 29% with revenues of $108.4 billion. The company has outperformed the market by 15.2% year-to-date. However, the stock received a Zacks Rank #3 (Hold) rating with mixed estimate revisions. Meanwhile, Surgery Partners is expected to report a 46.2% year-over-year earnings decline for the same quarter.
Halper Sadeh LLC, an investor rights law firm, is investigating three companies for potential securities law violations and breaches of fiduciary duties. Surgery Partners (SGRY) is being acquired by HealthSpan Partners for $23.50 per share, Range Resources (RRC) is being sold to EQT Corporation with Range shareholders expected to own 27% of the combined entity, and MidCap Financial Investment Corporation (MFIC) is being acquired by Ares Capital with MFIC shareholders expected to own 5% of the combined company. The firm is seeking increased consideration and additional disclosures on behalf of shareholders.
The Nasdaq rose 0.82% on October 26, 2026, driven by AI optimism following Anthropic's IPO filing. Tesla surged 5% on a Barclays upgrade, while Meta fell 2% after announcing a $95 billion AI infrastructure investment plan. The S&P 500 gained 0.70% and the Dow edged up 0.28% as investors favored tech and real estate stocks.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.